✦ LIBER ✦

Conditional median survival of patients with advanced carcinoma : Surveillance, epidemiology, and end results data

✍ Scribed by Ikuko Kato; Richard K. Severson; Ann G. Schwartz

Publisher: John Wiley and Sons
Year: 2001
Tongue: English
Weight: 114 KB
Volume: 92
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(20011015)92:8<2211::aid-cncr1565>3.0.co;2-w

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The conditional probability of survival

The conditional probability of survival of patients with primary malignant brain tumors : Surveillance, epidemiology, and end results (SEER) data

✍ Faith G. Davis; Bridget J. McCarthy; Sally Freels; Varant Kupelian; Melissa L. B 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 113 KB 👁 2 views

## Background: Five-year survival estimates in standard cancer reports provide a general description of disease outcome that is useful for surveillance and comparison purposes. however, for cancer survivors these overall survival rates may be discouraging, and the relevant question regarding an ind

Inflammatory breast carcinoma incidence

Inflammatory breast carcinoma incidence and survival : The Surveillance, Epidemiology, and End Results program of the National Cancer Institute, 1975-1992

✍ Shine Chang; Sheryl L. Parker; Tuan Pham; Aman U. Buzdar; Stephen D. Hursting 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB 👁 2 views

## Background: Little is known about the cause of inflammatory breast carcinoma (ibc), the most aggressive form of breast cancer. to the authors' knowledge, no studies have investigated whether ibc risk factors are different from those for breast carcinoma overall, and there has been only one repor

Anastrozole versus megestrol acetate in

Anastrozole versus megestrol acetate in the treatment of postmenopausal women with advanced breast carcinoma : Results of a survival update based on a combined analysis of data from two mature phase III trials

✍ Aman U. Buzdar; Walter Jonat; Anthony Howell; Stephen E. Jones; Carl P. Blomqvis 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 146 KB 👁 2 views

Medical University of BACKGROUND. This report presents the results of a survival update based on the combined data from two studies that compared the efficacy and tolerability of anastrozole (1 or 10 mg once daily), a selective, nonsteroidal aromatase inhibitor administered orally, and megestrol ace